The anthelmintic efficacy and the safety of a combination of imidacloprid and moxidectin spot-on in cats and dogs under field conditions in Europe.
Hellmann
K
K
Klifovet AG Munich, D-80689, Germany.
Knoppe
T
T
Radeloff
I
I
Heine
J
J
D000723:Ancylostomatoidea / Q000187:drug effects; D000818:Animals; D000871:Anthelmintics / Q000009:adverse effects / Q000627:therapeutic use*; D002371:Cat Diseases / Q000188:drug therapy* / Q000469:parasitology; D002415:Cats; D004283:Dog Diseases / Q000188:drug therapy* / Q000469:parasitology; D004285:Dogs; D004359:Drug Therapy, Combination; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D018942:Macrolides / Q000009:adverse effects / Q000627:therapeutic use*; D009349:Nematode Infections / Q000188:drug therapy / Q000469:parasitology / Q000662:veterinary*; D000073943:Neonicotinoids; D009574:Nitro Compounds; D010270:Parasite Egg Count; D014119:Toxocara / Q000187:drug effects; D016896:Treatment Outcome
D000871:Anthelmintics; D007093:Imidazoles; D018942:Macrolides; D000073943:Neonicotinoids; D009574:Nitro Compounds; C082359:imidacloprid; C027837:moxidectin